| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $623.5M | +13.2% |
| Cost of Revenue | $132.0M | +40.6% |
| Gross Profit | $491.6M | +7.5% |
| R&D Expense | $237.8M | +20.9% |
| SG&A Expense | $98.9M | +10.9% |
| Operating Income | -$146.5M | -24.5% |
| Pre-tax Income | -$116.3M | -40.1% |
| Income Tax | $13.0M | +1.9% |
| Net Income | -$129.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $202.5M | +9.1% |
| Short-term Investments | $681.2M | +98.4% |
| Accounts Receivable | $242.8M | +25.9% |
| Current Assets | $1.30B | +47.9% |
| Total Assets | $1.79B | +7.7% |
| Current Liabilities | $659.0M | -7.2% |
| Stockholders' Equity | $598.7M | +31.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $147.4M | +28.0% |
| Capital Expenditures | $12.6M | +88.6% |
| Investing Cash Flow | -$837K | +99.8% |
| Financing Cash Flow | -$129.7M | -134.9% |
| Free Cash Flow | $134.8M | +24.2% |
| -35.0% |
| EPS (Basic) | -$1.13 | -31.4% |
| EPS (Diluted) | -$1.13 | -31.4% |